首页> 外文期刊>Obesity >The effect of pioglitazone and resistance training on body composition in older men and women undergoing hypocaloric weight loss.
【24h】

The effect of pioglitazone and resistance training on body composition in older men and women undergoing hypocaloric weight loss.

机译:吡格列酮和抵抗训练对经历低热量减肥的老年男性和女性身体成分的影响。

获取原文
获取原文并翻译 | 示例

摘要

Age-related increases in ectopic fat accumulation are associated with greater risk for metabolic and cardiovascular diseases, and physical disability. Reducing skeletal muscle fat and preserving lean tissue are associated with improved physical function in older adults. PPARgamma-agonist treatment decreases abdominal visceral adipose tissue (VAT) and resistance training preserves lean tissue, but their effect on ectopic fat depots in nondiabetic overweight adults is unclear. We examined the influence of pioglitazone and resistance training on body composition in older (65-79 years) nondiabetic overweight/obese men (n = 48, BMI = 32.3 +/- 3.8 kg/m(2)) and women (n = 40, BMI = 33.3 +/- 4.9 kg/m(2)) during weight loss. All participants underwent a 16-week hypocaloric weight-loss program and were randomized to receive pioglitazone (30 mg/day) or no pioglitazone with or without resistance training, following a 2 x 2 factorial design. Regional body composition was measured at baseline and follow-up using computed tomography (CT). Lean mass was measured using dual X-ray absorptiometry. Men lost 6.6% and women lost 6.5% of initial body mass. The percent of fat loss varied across individual compartments. Men who were given pioglitazone lost more visceral abdominal fat than men who were not given pioglitazone (-1,160 vs. -647 cm(3), P = 0.007). Women who were given pioglitazone lost less thigh subcutaneous fat (-104 vs. -298 cm(3), P = 0.002). Pioglitazone did not affect any other outcomes. Resistance training diminished thigh muscle loss in men and women (resistance training vs. no resistance training men: -43 vs. -88 cm(3), P = 0.005; women: -34 vs. -59 cm(3), P = 0.04). In overweight/obese older men undergoing weight loss, pioglitazone increased visceral fat loss and resistance training reduced skeletal muscle loss. Additional studies are needed to clarify the observed gender differences and evaluate how these changes in body composition influence functional status.
机译:与年龄有关的异位脂肪积累增加与代谢和心血管疾病以及身体残疾的更大风险相关。减少骨骼肌脂肪和保持瘦组织与老年人身体机能的改善有关。 PPARγ激动剂治疗可减少腹部内脏脂肪组织(VAT),阻力训练可保留瘦组织,但尚不清楚它们对非糖尿病超重成年人异位脂肪库的作用。我们检查了吡格列酮和抵抗训练对年龄较大(65-79岁)的非糖尿病超重/肥胖男性(n = 48,BMI = 32.3 +/- 3.8 kg / m(2))和女性(n = 40 ,减肥期间的BMI = 33.3 +/- 4.9 kg / m(2)。所有参与者均接受了为期16周的低热量减肥计划,并按照2 x 2析因设计随机分配接受吡格列酮(30 mg /天)或不接受吡格列酮加或不加抵抗训练。在基线和随访时使用计算机断层扫描(CT)测量区域身体成分。使用双X射线吸收法测量瘦体重。男性减少了6.6%,女性减少了6.5%的初始体重。脂肪流失的百分比因各个隔室而异。服用吡格列酮的男性比不服用吡格列酮的男性减少了更多的内脏腹部脂肪(-1,160 vs. -647 cm(3),P = 0.007)。服用吡格列酮的女性失去的大腿皮下脂肪较少(-104比-298 cm(3),P = 0.002)。吡格列酮不影响任何其他结局。阻力训练可减少男女的大腿肌肉损失(阻力训练与无阻力训练的男性:-43 vs.-88 cm(3),P = 0.005;女性:-34 vs. -59 cm(3),P = 0.04)。在体重减轻的超重/肥胖老年男性中,吡格列酮增加了内脏脂肪的减少,而阻力训练减少了骨骼肌的损失。需要进一步的研究来澄清观察到的性别差异,并评估这些身体成分的变化如何影响功能状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号